That only holds true if the company frequently releases pump news. Typically, all biotech shares surge during anticipated phase 3 results, which is standard practice. Additionally, since we were trading at the bottom of the chart, experiencing a few hundred percent increase is normal. Unless she intends to ensure an R/S and then announce the data, followed by an offer to capture big money if that's her game plan?
One little thing is you dont actually meet with the board you do it all on a form, its a detailed form and she and the company lays out their plan on how to get the price back over a dime... to one satisfy the delisting due to being below the 10 cent bid price for over 10 days...in May they have to either be over a dollar again of ask for another 180 day extension for being under the dollar minimum bid... these are two different rules violations and two different forms... She was already over the 10 cents and would have stayed there had she not sent the Pre 14 out in that 8-K Even without being on the AACR abstract list, just the speculation of a positive Phase III result would have kept it over a dime... She fucked up big time there and she and her company are the only ones who know what the time frame for having to get the form back to them is so my guess is she is holding onto the Phase III and will release it about 3 or 4 days before she sends in the form and will use the positive results as their means of getting to both 10 cents and a dollar. I have looked every where to see if there is a way to find out what the time frame is that NASDQ gave them for having that form returned but no luck so far
Market Data 
Markets 
AI
